Concepedia

Author

Honghui Zhou

Janssen (United States)ORCID

Also Known As

Amarnath Sharma, Antonio Tugores, Dan Turner, Den Anker, Den Van, H H Zhou, H ZHOU, H Zhou, H. Zhou, H.B. Zhou

247

Publications

6.7K

Citations

44

H-Index

135

Concepts

All Affiliations

Janssen (United States)Janssen (Belgium)SpringhouseNovartis (United States)Johnson & Johnson (United States)
HZ

About

Honghui Zhou is an author at Janssen (United States) specializing in medicine, immunology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

53

2.8K

2

Public Health

5

5

253

3

Education

2

2

61

4

Health Sciences

1

1

14

5

Nursing

1

1

18

Honghui Zhou

×

101

Publications

5.1K

Citations

37

H-Index

YearCitations

Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis

Omoniyi J. Adedokun, William J. Sandborn, Brian G. Feagan,

Gastroenterology

2014

328

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Joyce Ford,

European Journal of Clinical Pharmacology

2009

319

Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Marion Blank,

Clinical Therapeutics

2011

288

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

David J. Shealy, Ann Cai, Kim Staquet,

mAbs

2010

239

Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies

Liang Wu, Honghui Zhou, Haiyan Lin,

Reproduction

2011

191

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann,

The Journal of Clinical Pharmacology

2007

191

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

Yaowei Zhu, Chuanpu Hu, Ming Lu,

The Journal of Clinical Pharmacology

2009

166

Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab

Jacqueline Benson, Clifford Sachs, George Treacy,

Nature Biotechnology

2011

140

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

Omoniyi J. Adedokun, Zhenhua Xu, Colleen Marano,

Journal of Crohn s and Colitis

2016

112

Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

Zhenhua Xu, Kathleen Seitz, Adedigbo A. Fasanmade,

The Journal of Clinical Pharmacology

2008

106

Page 1